Breast Cancer-Targets and Therapy

Papers
(The TQCC of Breast Cancer-Targets and Therapy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
<p>Resistance and Overcoming Resistance in Breast Cancer</p>45
A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer34
Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis17
Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells16
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action16
Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy15
<p>Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women</p>14
Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review13
Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis11
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer11
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data10
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab10
An Update on the Molecular Pathology of Metaplastic Breast Cancer8
The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up8
Systematic Review of Breast-Q: A Tool to Evaluate Post-Mastectomy Breast Reconstruction8
<p>Breast Cancer Detection Using Low-Frequency Bioimpedance Device</p>7
<p>The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia</p>7
<p>Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy</p>7
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review7
Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib7
<p>Alpelisib in the Treatment of Breast Cancer: A Short Review on the Emerging Clinical Data</p>7
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers6
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?6
Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective6
<p>Quality of Life Among Breast Cancer Patients Attending Hawassa University Comprehensive Specialized Hospital Cancer Treatment Center</p>6
<p>Breast Self-Examination Practice Among Women in Jimma, Southwest Ethiopia: A Community-Based Cross-Sectional Study</p>6
<p>Knowledge and Practice of Breast Self-Examination Among Young Women in Tertiary Education in Addis Ababa, Ethiopia</p>6
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications6
Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions5
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients5
Development and Validation of an MRI Radiomics-Based Signature to Predict Histological Grade in Patients with Invasive Breast Cancer5
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold5
Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better5
<p>Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy</p>4
Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer4
Identifying Risk Factors of Breast Cancer Among Women Attending Selected Hospitals of Addis Ababa City: Hospital-Based Unmatched Case-Control Study4
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment4
FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival4
Genetic Influences in Breast Cancer Drug Resistance4
<p>A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma</p>4
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment4
Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors4
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer4
Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer4
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal3
Chloride Intracellular Channel 1 is a Potential Biomarker for Breast Cancer3
Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia3
Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer3
<p>Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility</p>3
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series3
miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells3
Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?3
Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia3
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound3
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer3
<p>Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer</p>3
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer3
Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth3
Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis3
The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer3
Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer3
Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer3
Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment3
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women3
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection3
<p>Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study</p>3
Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective3
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib3
0.025116920471191